Sharma, N., Naraev, B. G., Engelman, E. S., Zimmerman, M. B., Bushnell, D. L., O’Dorisio, T. M., . . . Halfdanarson, T. R. (2017). Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors. Pancreas.
Dyfyniad Arddull ChicagoSharma, Nancy, et al. "Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors." Pancreas 2017.
Dyfyniad MLASharma, Nancy, et al. "Peptide Receptor Radionuclide Therapy (PRRT) Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors." Pancreas 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.